Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2005
12/21/2005EP1606388A2 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
12/21/2005EP1606387A2 Vectors used to create hybrid constant regions
12/21/2005EP1606385A2 Plant production of immunoglobulins with reduced fucosylation
12/21/2005EP1606319A2 Treatment of viral infections
12/21/2005EP1606318A2 Improved fc fusion proteins
12/21/2005EP1606317A2 Anti-il-22ra antibodies and binding partners and methods of using in inflammation
12/21/2005EP1606316A2 Anti-il-20 antibodies and binding partners and methods of using in inflammation
12/21/2005EP1606315A2 Antigen-presenting complex-binding compositions and uses thereof
12/21/2005EP1606314A2 Fc REGION VARIANTS
12/21/2005EP1606305A2 Nucleic acid compounds for inhibiting angiogenesis and tumor growth
12/21/2005EP1605975A1 Composition and method for the treatment and prevention of enteric bacterial infections
12/21/2005EP1605974A2 Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
12/21/2005EP1605961A2 Polypeptide compounds for inhibiting angiogenesis and tumor growth
12/21/2005EP1605893A2 Trans-membrane-antibody induced inhibition of apoptosis
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/21/2005EP1534754A4 Bi-specific antigen-binding compositions and related methods
12/21/2005EP1335931B1 Derivatisation of proteins in aqueous solution
12/21/2005EP1276501B1 Method for treatment of tumors using photodynamic therapy
12/21/2005EP1265916B1 Therapeutic anti-cytomegalovirus compounds
12/21/2005EP1224465B1 Detection of hla-g
12/21/2005EP1218518B1 Dna polymerase lambda and uses thereof
12/21/2005EP1214600B1 Determination of adrenomedullin-binding proteins
12/21/2005EP1000143B1 Frazzled nucleotide sequences, expression products, compositions and uses
12/21/2005EP0994947B1 Mu-1, member of the cytokine receptor family
12/21/2005EP0777474B1 Methods for the treatment of inflammatory joint disease
12/21/2005CN1711476A Non-competitive immunoassay for small analytes
12/21/2005CN1711283A Kit for assaying human low-molecular weight CD14 and antibody
12/21/2005CN1711282A Inhibition of Il-17 production
12/21/2005CN1711106A Agents for the diagnosis and treatment of tumours that expose altered proteins on the cell surface
12/21/2005CN1711105A Compositions and methods for treating or preventing pneumococcal infection
12/21/2005CN1232641C Modulator for function of receptor of TNF/NGF receptor family and other protein
12/21/2005CN1232537C Heavy chain variable region single domain antibody reinforced fusion protein VH-LDP-AE
12/21/2005CN1232530C Ethene receptor protein of wheat and its coding sequence
12/20/2005US6977159 Methods for inhibiting cutaneous inflammation and hyperpigmentation
12/20/2005US6977158 Mammalian IAP gene family, primers, probes, and detection methods
12/20/2005US6977144 Nucleic acids encoding Selected Interacting Domain (SID registered) polypeptides binding selectively to a peptide encoded by a pathogenic strain of the hepatitis C virus; genetic engineering; gene therapy; bactericides;
12/20/2005US6977078 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
12/20/2005CA2321610C C-myc coding region determinant-binding protein (crd-bp)
12/20/2005CA2266319C Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
12/15/2005WO2005118887A2 Human antibodies interacting with hiv gp41
12/15/2005WO2005118864A2 Antibodies and related molecules that bind to psca proteins
12/15/2005WO2005118815A1 Polypeptides having dna polymerase activity
12/15/2005WO2005118813A2 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein
12/15/2005WO2005118811A1 Novel polypeptide useful for diagnosis and treatment of cancer
12/15/2005WO2005118786A2 Splice variants of peptide yy, neuropeptide y, pancreatic peptide y and amylin, and uses thereof
12/15/2005WO2005118646A2 Epitope directed selection of antibodies to murine tissue factor
12/15/2005WO2005118645A1 Antibody specific for a chondroitin sulphate epitope
12/15/2005WO2005118644A2 Binding molecules capable of neutralizing rabies virus and uses thereof
12/15/2005WO2005118643A2 Antibodies to angiogenesis inhibiting domains of cd148
12/15/2005WO2005118642A2 Bispecific fusion antibodies with enhanced serum half-life
12/15/2005WO2005118637A1 Treatment of inflammatory conditions
12/15/2005WO2005118635A2 Anti-cd3 antibodies and methods of use thereof
12/15/2005WO2005118631A1 Novel protein complex and use thereof
12/15/2005WO2005118630A2 Peptides for the treatment of diabetes
12/15/2005WO2005118629A1 BINDING MOIETIES BASED ON SHARK IgNAR DOMAINS
12/15/2005WO2005118627A2 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use
12/15/2005WO2005117986A2 Antibody drug conjugates and methods
12/15/2005WO2005117978A2 Method for treating multiple sclerosis
12/15/2005WO2005117976A2 Method of increasing radiation sensitivity by inhibition of beta one integrin
12/15/2005WO2005117975A2 Methods for treating vascular disease
12/15/2005WO2005117974A2 Cancer treatment method by inhibiting mage gene expression or function
12/15/2005WO2005117973A2 Bispecific binding agents for modulating biological activity
12/15/2005WO2005117972A2 Preventing autoimmune disease by using an anti-cd20 antibody
12/15/2005WO2005117971A2 Regulators of angiogenesis
12/15/2005WO2005117970A2 Antibodies of angiogenesis inhibiting domains of cd148
12/15/2005WO2005117969A2 Solution phase biopanning method using engineered decoy proteins
12/15/2005WO2005117968A2 Compositions and methods comprising an egfl7 antagonist for modulating vascular development
12/15/2005WO2005117967A2 Anti-il-9 antibody formulations and uses thereof
12/15/2005WO2005117966A1 Method to reduce hepatotoxicity of fas-mediated apoptosis-inducing agents
12/15/2005WO2005117941A2 Methods and compositions for the treatment of polycystic diseases
12/15/2005WO2005117936A2 Method for enhancing or inhibiting insulin-like growth factor-i
12/15/2005WO2005117897A2 Hepoxilins and modulators of ichthyin for treatment skin disorders
12/15/2005WO2005117848A2 Vascular targets for detecting, imaging and treating neoplasia or neovasculature
12/15/2005WO2005099361A3 MHC CLASS I - PEPTIDE-ANTIBODY CONJUGATES WITH MODIFIED β2-MICROGLOBULIN
12/15/2005WO2005083126A3 Alterations of fibulin genes in macular degeneration
12/15/2005WO2005082938A3 Anti-human tenascin monoclonal antibody
12/15/2005WO2005080430A8 Anti-ube4a/ufd2b polyclonal antibody and its use thereof as diagnostic and prognostic marker of 11q23 region alterations
12/15/2005WO2005079848A3 Agonists and antagonists of p28 ebi3 and wsx/tccr for treating immune disorders
12/15/2005WO2005070966A3 Fusion polypeptides capable of activating receptors
12/15/2005WO2005058359A3 Method for neutralizing effects of crp for increasing immune reactions to hiv
12/15/2005WO2005051423A3 Methods and agents for immune modulation and methods for identifying immune modulators
12/15/2005WO2005046564A3 Diagnosis and treatment of liver fibrosis
12/15/2005WO2005035576A3 Method of resisting osteoclast formation
12/15/2005WO2005033267A3 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof
12/15/2005WO2005033145A8 Antibodies to nik, their preparation and use
12/15/2005WO2005023993A3 Methods and compositions for generation of germline human antibody genes
12/15/2005WO2005012359A3 Anti-vegf antibodies
12/15/2005WO2004105573A3 Method of diagnosis of cancer based on gene expression profiles in cells
12/15/2005WO2004096989A9 Single chain antigen-binding polypeptides for polymer conjugation
12/15/2005WO2004000102A3 Method for predicting response to epidermal growth factor receptor-directed therapy
12/15/2005WO2003087324A3 Antibody gene transfer and recombinant aav
12/15/2005WO2003062370A3 Multimeric proteins and methods of making and using same
12/15/2005WO2002083921A8 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
12/15/2005WO2002083855A3 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/15/2005US20050277764 Nucleic acid sequence encoding a mammalian MDM2 binding protein for modulating the G1 phase of the cell cycle via altering expression and/or activity of a mammalian MDM2 binding protein
12/15/2005US20050277173 inoculating human lymphocytes, mitogens or polyclonal activators, to cultures and control cultures, then determining the degree of apoptosis and proliferation in the cultures; design of synthetic immunogens; screening of ligands that yield pharmacological effects
12/15/2005US20050277162 Detection and modulation of cancer stem cells
12/15/2005US20050277151 NTR3, a novel member of the TNF- receptor supergene family
12/15/2005US20050277132 Nematode GS-like sequences
12/15/2005US20050276823 Methods and compositions for preventing oxidative degradation of proteins
1 ... 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 ... 1494